Scale Biosciences
AcquiredSingle Cell Library Preparation Kits
- Business Model
- B2B
- Website
- scale.bio
- Last Round
- Series AJan 2023
- Rounds
- 1
About
Single-cell genomics company offering massively parallelized barcoding technology to enable accessible, flexible single-cell analysis at scale.
Summary
Scale Biosciences is a Biotech company based in United States. Its most recent funding was a Series A round in Jan 2023. Investors include ARCH Venture Partners and Tao Capital Partners.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...